Genome-wide association analyses identify new risk variants and the genetic architecture of amyotrophic lateral sclerosisRobert Swingler, Katarina Vrabec, Metka Ravnik‐Glavač et al.|Nature Genetics|2016Cited by 633
Autologous mesenchymal stem cells for the treatment of secondary progressive multiple sclerosis: an open-label phase 2a proof-of-concept studyPeter Connick, Siddharthan Chandran, Madhan Kolappan et al.|The Lancet Neurology|2012Cited by 606
TDP-43 loss and ALS-risk SNPs drive mis-splicing and depletion of UNC13AAnna‐Leigh Brown, Pietro Fratta, Mary Poss et al.|Nature|2022Cited by 510
Postmortem Cortex Samples Identify Distinct Molecular Subtypes of ALS: Retrotransposon Activation, Oxidative Stress, and Activated GliaOliver H. Tam, Molly Hammell, Robert W. Baloh et al.|Cell Reports|2019Cited by 333
FUS-SMN Protein Interactions Link the Motor Neuron Diseases ALS and SMATomohiro Yamazaki, Robin Reed, Shi Chen et al.|Cell Reports|2012Cited by 255